Skip to main content
Erschienen in: Rechtsmedizin 1/2018

01.02.2018 | Androgene | CME

Nebenwirkungen anaboler Substanzen

verfasst von: Prof. A. Büttner, D. Thieme, M. Bidlingmaier, B. Madea

Erschienen in: Rechtsmedizin | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Nebenwirkungen existieren für alle als Dopingmittel verbotene Substanzklassen, im Vordergrund steht aber die Gruppe der anabol-androgenen Steroide. Die Vielzahl der beschriebenen Nebenwirkungen lässt sich funktionell unterscheiden in direkte Wirkung an beteiligten Rezeptoren (Androgen‑, Östrogen- oder Gestagenrezeptoren, γ‑Aminobuttersäure[GABA]-Rezeptoren), indirekte Wirkungen durch Suppression der körpereigenen Steroidsynthese, mittelbare Wirkungen durch schädigende Biotransformationsprodukte. Die aus den unterschiedlichen Wirkprofilen resultierenden Nebenwirkungen werden systematisch dargestellt.
Literatur
1.
Zurück zum Zitat Dhar R, Stout CW, Link MS, Homoud MK, Weinstock J, Estes NA 3rd (2005) Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clin Proc 80:1307–1315CrossRefPubMed Dhar R, Stout CW, Link MS, Homoud MK, Weinstock J, Estes NA 3rd (2005) Cardiovascular toxicities of performance-enhancing substances in sports. Mayo Clin Proc 80:1307–1315CrossRefPubMed
2.
Zurück zum Zitat Hartgens F, Juipers H (2004) Effects of androgenic-anabolic steroids in athletes. Sports Med 34:513–554CrossRefPubMed Hartgens F, Juipers H (2004) Effects of androgenic-anabolic steroids in athletes. Sports Med 34:513–554CrossRefPubMed
3.
Zurück zum Zitat Kohler M, Thevis M, Schänzer W, Püschel K (2008) Gesundheitsschäden und Todesfälle durch Doping. Rechtsmedizin 18:177–118CrossRef Kohler M, Thevis M, Schänzer W, Püschel K (2008) Gesundheitsschäden und Todesfälle durch Doping. Rechtsmedizin 18:177–118CrossRef
4.
Zurück zum Zitat Tokish JM, Kocher MS, Hawkins RJ (2004) Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med 32:1543–1553CrossRefPubMed Tokish JM, Kocher MS, Hawkins RJ (2004) Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med 32:1543–1553CrossRefPubMed
5.
Zurück zum Zitat Musshoff F, Daldrup T, Ritsch M (1997) Anabole Steroide auf dem deutschen Schwarzmarkt. Arch Kriminol 199:152–158PubMed Musshoff F, Daldrup T, Ritsch M (1997) Anabole Steroide auf dem deutschen Schwarzmarkt. Arch Kriminol 199:152–158PubMed
6.
Zurück zum Zitat Büttner A, Thieme D (2010) Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships. In: Thieme D, Hemmersbach P (Hrsg) Doping in sports. Handbook of experimental pharmacology, Bd. 195. Springer, Berlin Heidelberg New York, S 459–483CrossRef Büttner A, Thieme D (2010) Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships. In: Thieme D, Hemmersbach P (Hrsg) Doping in sports. Handbook of experimental pharmacology, Bd. 195. Springer, Berlin Heidelberg New York, S 459–483CrossRef
7.
Zurück zum Zitat Kistler L (2006) Todesfälle bei Anabolikamissbrauch – Todesursache, Befunde und rechtsmedizinische Aspekte. Dissertation, Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München Kistler L (2006) Todesfälle bei Anabolikamissbrauch – Todesursache, Befunde und rechtsmedizinische Aspekte. Dissertation, Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München
8.
Zurück zum Zitat Lüderwald S, Zinka B, Thieme D, Eisenmenger W (2008) Missbrauch von anabolen androgenen Steroiden. Todesfälle bei Freizeitbodybuildern. Rechtsmedizin 18(3):183–188CrossRef Lüderwald S, Zinka B, Thieme D, Eisenmenger W (2008) Missbrauch von anabolen androgenen Steroiden. Todesfälle bei Freizeitbodybuildern. Rechtsmedizin 18(3):183–188CrossRef
9.
Zurück zum Zitat Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 38:644–651CrossRefPubMed Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 38:644–651CrossRefPubMed
10.
11.
Zurück zum Zitat Karch S, Drummer O (2015) Anabolic steroids. In: Karch S (Hrsg) Karch’s pathology of drugs of abuse, 5th. CRC Press, Boca Raton FL, S 755–783CrossRef Karch S, Drummer O (2015) Anabolic steroids. In: Karch S (Hrsg) Karch’s pathology of drugs of abuse, 5th. CRC Press, Boca Raton FL, S 755–783CrossRef
12.
Zurück zum Zitat Dickerman RD, McConathy WJ, Schaller F, Zachariah NY (1996) Cardiovascular complications and anabolic steroids. Eur Heart J 17:1912CrossRefPubMed Dickerman RD, McConathy WJ, Schaller F, Zachariah NY (1996) Cardiovascular complications and anabolic steroids. Eur Heart J 17:1912CrossRefPubMed
13.
Zurück zum Zitat Di Paolo M, Agozzino M, Toni C, Luciani AB, Molendini L, Scaglione M, Inzani F, Pasotti M, Buzzi F, Arbustini E (2007) Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol 114:114–117CrossRefPubMed Di Paolo M, Agozzino M, Toni C, Luciani AB, Molendini L, Scaglione M, Inzani F, Pasotti M, Buzzi F, Arbustini E (2007) Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol 114:114–117CrossRefPubMed
14.
Zurück zum Zitat Ferenchick GS (1991) Anabolic/androgenic steroid abuse and thrombosis: Is there a connection? Medical Hypotheses 35(1):27–31CrossRefPubMed Ferenchick GS (1991) Anabolic/androgenic steroid abuse and thrombosis: Is there a connection? Medical Hypotheses 35(1):27–31CrossRefPubMed
15.
Zurück zum Zitat Fineschi V, Baroldi G, Monciotti F, Paglicci RL, Turillazzi E (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253–255PubMed Fineschi V, Baroldi G, Monciotti F, Paglicci RL, Turillazzi E (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253–255PubMed
16.
Zurück zum Zitat Fineschi V, Riezzo I, Centini F, Silingardi E, Licata M, Beduschi G, Karch SB (2007) Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121:48–53CrossRefPubMed Fineschi V, Riezzo I, Centini F, Silingardi E, Licata M, Beduschi G, Karch SB (2007) Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med 121:48–53CrossRefPubMed
17.
Zurück zum Zitat Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death – a case report and review of the literature. Int J Legal Med 111:261–264CrossRefPubMed Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death – a case report and review of the literature. Int J Legal Med 111:261–264CrossRefPubMed
18.
Zurück zum Zitat Kennedy MC, Lawrence C (1993) Anabolic steroid abuse and cardiac death. Med J Aust 158:346–348PubMed Kennedy MC, Lawrence C (1993) Anabolic steroid abuse and cardiac death. Med J Aust 158:346–348PubMed
19.
Zurück zum Zitat Luke JL, Farb A, Virmani R, Sample RH (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. J Forensic Sci 35:1441–1447CrossRefPubMed Luke JL, Farb A, Virmani R, Sample RH (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. J Forensic Sci 35:1441–1447CrossRefPubMed
20.
Zurück zum Zitat Madea B, Grellner W (1996) Langzeitfolgen und Todesfälle bei Anabolikaabusus. Rechtsmedizin 6:33–38 Madea B, Grellner W (1996) Langzeitfolgen und Todesfälle bei Anabolikaabusus. Rechtsmedizin 6:33–38
21.
Zurück zum Zitat Montisci M, El Mazloum R, Cecchetto G, Terranova C, Ferrara SD, Thiene G, Basso C (2012) Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 217:e13–e18CrossRefPubMed Montisci M, El Mazloum R, Cecchetto G, Terranova C, Ferrara SD, Thiene G, Basso C (2012) Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int 217:e13–e18CrossRefPubMed
22.
Zurück zum Zitat Thiblin I, Mobini-Far H, Frisk M (2009) Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine. Forensic Sci Int 184:e7–e11CrossRefPubMed Thiblin I, Mobini-Far H, Frisk M (2009) Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine. Forensic Sci Int 184:e7–e11CrossRefPubMed
23.
Zurück zum Zitat Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V (2015) Anabolic Androgenic Steroid (AAS) related deaths: Autoptic, histopathological and toxicological findings. Curr Neuropharmacol 13:146–159CrossRefPubMedPubMedCentral Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V (2015) Anabolic Androgenic Steroid (AAS) related deaths: Autoptic, histopathological and toxicological findings. Curr Neuropharmacol 13:146–159CrossRefPubMedPubMedCentral
24.
25.
Zurück zum Zitat Akhter J, Hyder S, Ahmed M (1994) Cerebrovascular accident associated with anabolic steroid use in a young man. Neurology 44:2405–2406CrossRefPubMed Akhter J, Hyder S, Ahmed M (1994) Cerebrovascular accident associated with anabolic steroid use in a young man. Neurology 44:2405–2406CrossRefPubMed
26.
Zurück zum Zitat Alaraj AM, Chamoun RB, Dahdaleh NS, Haddad GF, Comair YG (2005) Spontaneous subdural haematoma in anabolic steroids dependent weight lifters: reports of two cases and review of literature. Acta Neurochir 147:85–88CrossRefPubMed Alaraj AM, Chamoun RB, Dahdaleh NS, Haddad GF, Comair YG (2005) Spontaneous subdural haematoma in anabolic steroids dependent weight lifters: reports of two cases and review of literature. Acta Neurochir 147:85–88CrossRefPubMed
27.
Zurück zum Zitat El Scheich T, Weber AA, Klee D, Schweiger D, Mayatepek E, Karenfort M (2013) Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse. J Pediatr Endocrinol Metab 26:161–165CrossRefPubMed El Scheich T, Weber AA, Klee D, Schweiger D, Mayatepek E, Karenfort M (2013) Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse. J Pediatr Endocrinol Metab 26:161–165CrossRefPubMed
28.
Zurück zum Zitat Frankle MA, Eichberg R, Zachariah SB (1988) Anabolic androgenic steroids and a stroke in an athlete. Arch Phys Med Rehabil 69:632–633PubMed Frankle MA, Eichberg R, Zachariah SB (1988) Anabolic androgenic steroids and a stroke in an athlete. Arch Phys Med Rehabil 69:632–633PubMed
29.
Zurück zum Zitat García-Esperón C, Hervás-García JV, Jiménez-González M, Pérez de la Ossa-Herrero N, Gomis-Cortina M, Dorado-Bouix L, López-Cancio Martínez E, Castaño-Duque CH, Millán-Torné M, Dávalos A (2013) Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature. Rev Neurol 56:327–331PubMed García-Esperón C, Hervás-García JV, Jiménez-González M, Pérez de la Ossa-Herrero N, Gomis-Cortina M, Dorado-Bouix L, López-Cancio Martínez E, Castaño-Duque CH, Millán-Torné M, Dávalos A (2013) Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature. Rev Neurol 56:327–331PubMed
30.
Zurück zum Zitat Harston GW, Batt F, Fan L, Okell TW, Sheerin F, Littlewood T, Kennedy J (2014) Lacunar infarction associated with anabolic steroids and polycythemia: a case report. Case Rep Neurol 6:34–37CrossRefPubMedPubMedCentral Harston GW, Batt F, Fan L, Okell TW, Sheerin F, Littlewood T, Kennedy J (2014) Lacunar infarction associated with anabolic steroids and polycythemia: a case report. Case Rep Neurol 6:34–37CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Jaillard AS, Hommel M, Mallaret M (1994) Venous sinus thrombosis associated with androgens in a healthy young man. Stroke 25:212–213CrossRefPubMed Jaillard AS, Hommel M, Mallaret M (1994) Venous sinus thrombosis associated with androgens in a healthy young man. Stroke 25:212–213CrossRefPubMed
32.
Zurück zum Zitat Kennedy MC, Corrigan AB, Pilbeam ST (1993) Myocardial infarction and cerebral haemorrhage in a young body builder taking anabolic steroids. Aust N Z J Med 23:713CrossRefPubMed Kennedy MC, Corrigan AB, Pilbeam ST (1993) Myocardial infarction and cerebral haemorrhage in a young body builder taking anabolic steroids. Aust N Z J Med 23:713CrossRefPubMed
34.
Zurück zum Zitat Mochizuki RM, Richter KJ (1988) Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Phys Sportsmed 16:109–111CrossRefPubMed Mochizuki RM, Richter KJ (1988) Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Phys Sportsmed 16:109–111CrossRefPubMed
35.
Zurück zum Zitat Pálfi S, Ungureán A, Vécsei L (1997) Basilar artery occlusion associated with anabolic steroid abuse in a 17-year-old bodybuilder. Eur Neurol 37:190–191CrossRefPubMed Pálfi S, Ungureán A, Vécsei L (1997) Basilar artery occlusion associated with anabolic steroid abuse in a 17-year-old bodybuilder. Eur Neurol 37:190–191CrossRefPubMed
36.
Zurück zum Zitat Sahraian MA, Mottamedi M, Azimi AR, Moghimi B (2004) Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report. BMC Neurol 4:22CrossRefPubMedPubMedCentral Sahraian MA, Mottamedi M, Azimi AR, Moghimi B (2004) Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report. BMC Neurol 4:22CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Santamarina RD, Besocke AG, Romano LM, Ioli PL, Gonorazky SE (2008) Ischemic stroke related to anabolic abuse. Clin Neuropharmacol 31:80–85CrossRefPubMed Santamarina RD, Besocke AG, Romano LM, Ioli PL, Gonorazky SE (2008) Ischemic stroke related to anabolic abuse. Clin Neuropharmacol 31:80–85CrossRefPubMed
38.
Zurück zum Zitat Shamloul RM, Aborayah AF, Hashad A, Abd-Allah F (2014) Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient. BMJ Case Rep 2014:bcr2013203033CrossRefPubMedPubMedCentral Shamloul RM, Aborayah AF, Hashad A, Abd-Allah F (2014) Anabolic steroids abuse-induced cardiomyopathy and ischaemic stroke in a young male patient. BMJ Case Rep 2014:bcr2013203033CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Shimada Y, Yoritaka A, Tanaka Y, Miyamoto N, Ueno Y, Hattori N, Takao U (2012) Cerebral infarction in a young man using high-dose anabolic steroids. J Stroke Cerebrovasc Dis 21(906):e9–e11 Shimada Y, Yoritaka A, Tanaka Y, Miyamoto N, Ueno Y, Hattori N, Takao U (2012) Cerebral infarction in a young man using high-dose anabolic steroids. J Stroke Cerebrovasc Dis 21(906):e9–e11
40.
Zurück zum Zitat Youssef MY, Alqallaf A, Abdella N (2011) Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease. BMJ Case Rep 2011:bcr1220103650CrossRefPubMedPubMedCentral Youssef MY, Alqallaf A, Abdella N (2011) Anabolic androgenic steroid-induced cardiomyopathy, stroke and peripheral vascular disease. BMJ Case Rep 2011:bcr1220103650CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Vore M, Montgomery C, Meyers M (1983) Steroid D‑ring glucuronides: characterization of a new class of cholestatic agents. Drug Metab Rev 14:1005–1019CrossRefPubMed Vore M, Montgomery C, Meyers M (1983) Steroid D‑ring glucuronides: characterization of a new class of cholestatic agents. Drug Metab Rev 14:1005–1019CrossRefPubMed
42.
Zurück zum Zitat Haupt HA, Rovere GD (1984) Anabolic steroids: A review of the literature. Am J Sports Med 12:469–484CrossRefPubMed Haupt HA, Rovere GD (1984) Anabolic steroids: A review of the literature. Am J Sports Med 12:469–484CrossRefPubMed
43.
Zurück zum Zitat Socas L, Zumbado M, Perez-Luzardo O, Ramos A, Pérez C, Hernández JR, Boada LD (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 39:e27CrossRefPubMedPubMedCentral Socas L, Zumbado M, Perez-Luzardo O, Ramos A, Pérez C, Hernández JR, Boada LD (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 39:e27CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Hansma P, Diaz FJ, Njiwaji C (2016) Fatal liver cyst rupture due to anabolic steroid use. A case presentation. Am J Forensic Med Pathol 37:21–22CrossRefPubMed Hansma P, Diaz FJ, Njiwaji C (2016) Fatal liver cyst rupture due to anabolic steroid use. A case presentation. Am J Forensic Med Pathol 37:21–22CrossRefPubMed
45.
Zurück zum Zitat Wenk M, Nieschlag E (2006) Male contraception: a realistic option? Eur J Contracept Reprod Health Care 11:69–80CrossRefPubMed Wenk M, Nieschlag E (2006) Male contraception: a realistic option? Eur J Contracept Reprod Health Care 11:69–80CrossRefPubMed
46.
Zurück zum Zitat Hallgren M, Pope HG Jr, Kanayama G, Hudson JI, Lundin A, Källmén H (2015) Anti-social behaviors associated with anabolic-androgenic steroid use among male adolescents. Eur Addict Res 21:321–326CrossRefPubMed Hallgren M, Pope HG Jr, Kanayama G, Hudson JI, Lundin A, Källmén H (2015) Anti-social behaviors associated with anabolic-androgenic steroid use among male adolescents. Eur Addict Res 21:321–326CrossRefPubMed
47.
Zurück zum Zitat Lundholm L, Frisell T, Lichtenstein P, Långström N (2015) Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10 365 general population men. Addiction 110:100–108CrossRefPubMed Lundholm L, Frisell T, Lichtenstein P, Långström N (2015) Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10 365 general population men. Addiction 110:100–108CrossRefPubMed
48.
Zurück zum Zitat Kanayama G, Hudson JI, Pope HG Jr (2010) Illicit anabolic-androgenic steroid use. Horm Behav 58:111–121CrossRefPubMed Kanayama G, Hudson JI, Pope HG Jr (2010) Illicit anabolic-androgenic steroid use. Horm Behav 58:111–121CrossRefPubMed
49.
50.
Zurück zum Zitat Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A (2014) The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict 23:371–377CrossRefPubMed Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A (2014) The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict 23:371–377CrossRefPubMed
51.
Zurück zum Zitat Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr (2009) Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry 166:642–645CrossRefPubMedPubMedCentral Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr (2009) Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry 166:642–645CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Grönbladh A, Nylander E, Hallberg M (2016) The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone. Brain Res Bull 126:127–137CrossRefPubMed Grönbladh A, Nylander E, Hallberg M (2016) The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone. Brain Res Bull 126:127–137CrossRefPubMed
53.
Zurück zum Zitat Wu Z, Bidlingmaier M, Dall R, Strasburger CJ (1999) Detection of doping with human growth hormone. Lancet 353:895CrossRefPubMed Wu Z, Bidlingmaier M, Dall R, Strasburger CJ (1999) Detection of doping with human growth hormone. Lancet 353:895CrossRefPubMed
54.
Zurück zum Zitat Bidlingmaier M, Suhr J, Ernst A, Wu Z, Keller A, Strasburger CJ, Bergmann A (2009) High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin Chem 55:445–453CrossRefPubMed Bidlingmaier M, Suhr J, Ernst A, Wu Z, Keller A, Strasburger CJ, Bergmann A (2009) High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin Chem 55:445–453CrossRefPubMed
Metadaten
Titel
Nebenwirkungen anaboler Substanzen
verfasst von
Prof. A. Büttner
D. Thieme
M. Bidlingmaier
B. Madea
Publikationsdatum
01.02.2018
Verlag
Springer Medizin
Erschienen in
Rechtsmedizin / Ausgabe 1/2018
Print ISSN: 0937-9819
Elektronische ISSN: 1434-5196
DOI
https://doi.org/10.1007/s00194-017-0203-9

Weitere Artikel der Ausgabe 1/2018

Rechtsmedizin 1/2018 Zur Ausgabe

Kasuistiken

Striae distensae

Neu im Fachgebiet Rechtsmedizin

Open Access 21.02.2024 | Fettleber | Originalien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Automatische Quantifizierung von Leberverfettung

21.02.2024 | Thrombozytopenie | CME

Knochenmarkhistologie bei Zytopenien

Beitrag zur hämatologischen Differenzialdiagnostik

Open Access 19.02.2024 | Künstliche Intelligenz | Originalien

Die Modelltransferierbarkeit von KI in der digitalen Pathologie

Potenzial und Realität